Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · July 19, 2022

First-Line Pembrolizumab Monotherapy for Advanced Hepatocellular Carcinoma

Clinical Cancer Research


Additional Info

Clinical Cancer Research
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
Clin. Cancer Res 2022 Jun 13;28(12)2547-2554, G Verset, I Borbath, M Karwal, C Verslype, H Van Vlierberghe, A Kardosh, V Zagonel, P Stal, D Sarker, DH Palmer, A Vogel, J Edeline, S Cattan, M Kudo, AL Cheng, S Ogasawara, B Daniele, SL Chan, JJ Knox, S Qin, AB Siegel, M Chisamore, K Hatogai, A Wang, RS Finn, AX Zhu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading